Tibotec Pharmaceuticals Ltd based in , IE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2010-10-28 ✅ Patent 8,178,694 granted on 2012-05-15

US20100272683A1

Chemistry; metallurgy

Heterocyclylaminoalkyl substituted benzimidazoles

#2 | 2010-07-22 ✅ Patent 8,034,835 granted on 2011-10-11

US20100183552A1

Chemistry; metallurgy

1-[[2-amino-3-(substituted alkyl)-3H-benzimidazolyl[methyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogs

#3 | 2010-02-09 ✅ Patent 7,659,404 granted on 2010-02-09

US10467609

Broad spectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors

#4 | 2010-02-04 ✅ Patent 7,863,306 granted on 2011-01-04

US20100029632A1

Chemistry; metallurgy

Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors

#5 | 2009-07-02 ✅ Patent 7,994,187 granted on 2011-08-09

US20090170855A1

Chemistry; metallurgy

HIV inhibiting 3,4-dihydro-imidazo[4,5-B]pyridin-5-ones

#6 | 2009-05-07 ✅ Patent 7,659,245 granted on 2010-02-09

US20090118312A1

Chemistry; metallurgy

Macrocylic inhibitors of hepatitis C virus

#7 | 2009-02-19 ✅ Patent 7,745,432 granted on 2010-06-29

US20090048242A1

Chemistry; metallurgy

(1,10b-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo[1,5 C][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors

#8 | 2008-12-11 ✅ Patent 7,803,836 granted on 2010-09-28

US20080306061A1

Chemistry; metallurgy

Aminophenylsulfonamide derivatives as HIV protease inhibitor

#9 | 2008-08-21 ✅ Patent 8,008,251 granted on 2011-08-30

US20080200503A1

Human necessities

Macrocyclic inhibitors of hepatitis C virus

#10 | 2008-07-10 ✅ Patent 7,514,427 granted on 2009-04-07

US20080167296A1

Chemistry; metallurgy

1,5,6,-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-inflective agents

#11 | 2008-06-19 ✅ Patent 7,956,196 granted on 2011-06-07

US20080146564A1

Chemistry; metallurgy

1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication

#12 | 2007-12-11 ✅ Patent 7,306,901 granted on 2007-12-11

US10214670

Methods and means for assessing HIV envelope inhibitor therapy

#13 | 2007-11-15 ✅ Patent 7,615,639 granted on 2009-11-10

US20070265295A1

Chemistry; metallurgy

1-pyridyl-benzofuro[3,2-b]pyridin-2(1H)-ones

#14 | 2007-03-15 ✅ Patent 7,772,411 granted on 2010-08-10

US20070060642A1

Chemistry; metallurgy

Process for the preparation of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate

#15 | 2006-08-31 ✅ Patent 7,442,705 granted on 2008-10-28

US20060194804A1

Chemistry; metallurgy

HIV replication inhibiting pyrimidines and triazines

#16 | 2005-10-06 ✅ Patent 7,763,641 granted on 2010-07-27

US20050222215A1

Chemistry; metallurgy

Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors

AssigneeID:

410030 ⎘